Plasma Levels of Enzalutamide and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer Undergoing Hemodialysis.

More about this publication

Clinical genitourinary cancer
  • Volume 17
  • Issue nr. 2
  • Pages e383-e386
  • Publication date 01-04-2019

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.